Mouse Study Suggests Lead May Trigger Schizophrenia
Monday, June 10, 2013
Behavioral and MRI study in mice points to a synergistic relationship between lead exposure and schizophrenia gene.
Identified a Key Protein in Maintaining the Identity of B Lymphocytes
Monday, June 10, 2013
This finding could be useful for the study of blood diseases such as lymphoma and leukemia.
Gene Mutation Gives Boost to Brain Cancer Cells
Monday, June 10, 2013
An international team of researchers has found that a singular gene mutation helps brain cancer cells to not just survive, but grow tumors rapidly.
Potential New Way to Suppress Tumor Growth Discovered
Monday, June 10, 2013
The new mechanism opens up the possibility of developing a new class of anti-cancer drugs.
Pronota is to Receive Patent on Biomarker for Diagnosing Renal Failure
Friday, June 07, 2013
USPTO has allowed Company’s patent for the use of a blood-based biomarker LG3.
SYGNIS Granted US Patent for QUALIPHI®
Monday, June 03, 2013
New patent opens SYGNIS and QUALIPHI® in a leading position in a €70 million global market.
4SC Gives Update on the Clinical Development of its Lead Cancer Compound Resminostat
Thursday, May 30, 2013
Data from completed Phase I part of SHORE study confirms the safety of the resminostat FOLFIRI combination and showing encouraging signs of clinical benefit
Enzyme-Activating Antibodies Revealed As Marker for Severe Rheumatoid Arthritis
Thursday, May 30, 2013
Finding could lead to earlier diagnosis and new, more aggressive treatment for worst cases.
Luminex Corporation and EMD Millipore Extend Their Global Supply and Distribution Agreement
Thursday, May 30, 2013
This long-term agreement strengthens the partnership and facilitates development of life science and protein assays.
|
|
|
| << | 1 2 3 4 5 6 7 | >> | | Showing Results 11 - 20 of 4179 |
|
|
